FDA Approved: POSACONAZOLE — Original Application (Biocon Phama Inc.)

View source ↗

Summary

FDA approved Biocon Phama Inc.'s original application for posaconazole, authorizing a generic formulation of the antifungal agent.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspergillosis
• Candidiasis
• Invasive Fungal Infections
• Mucormycosis
• Oropharyngeal Candidiasis

Drugs mentioned

• POSACONAZOLE (POSACONAZOLE)

Snippet

ORIG AP for POSACONAZOLE (POSACONAZOLE)